Papst, L.; Luzzati, R.; Carević, B.; Tascini, C.; Gorišek Miksić, N.; Vlahović Palčevski, V.; Djordjevic, Z.M.; Simonetti, O.; Sozio, E.; Lukić, M.;
et al. Antimicrobial Use in Hospitalised Patients with COVID-19: An International Multicentre Point-Prevalence Study. Antibiotics 2022, 11, 176.
https://doi.org/10.3390/antibiotics11020176
AMA Style
Papst L, Luzzati R, Carević B, Tascini C, Gorišek Miksić N, Vlahović Palčevski V, Djordjevic ZM, Simonetti O, Sozio E, Lukić M,
et al. Antimicrobial Use in Hospitalised Patients with COVID-19: An International Multicentre Point-Prevalence Study. Antibiotics. 2022; 11(2):176.
https://doi.org/10.3390/antibiotics11020176
Chicago/Turabian Style
Papst, Lea, Roberto Luzzati, Biljana Carević, Carlo Tascini, Nina Gorišek Miksić, Vera Vlahović Palčevski, Zorana M. Djordjevic, Omar Simonetti, Emanuela Sozio, Milica Lukić,
and et al. 2022. "Antimicrobial Use in Hospitalised Patients with COVID-19: An International Multicentre Point-Prevalence Study" Antibiotics 11, no. 2: 176.
https://doi.org/10.3390/antibiotics11020176
APA Style
Papst, L., Luzzati, R., Carević, B., Tascini, C., Gorišek Miksić, N., Vlahović Palčevski, V., Djordjevic, Z. M., Simonetti, O., Sozio, E., Lukić, M., Stevanović, G., Petek, D., & Beović, B., on behalf of the COVID-PPS Study Group.
(2022). Antimicrobial Use in Hospitalised Patients with COVID-19: An International Multicentre Point-Prevalence Study. Antibiotics, 11(2), 176.
https://doi.org/10.3390/antibiotics11020176